Literature DB >> 8800210

Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.

S Hornemann1, R Glockshuber.   

Abstract

Prion diseases are assumed to be caused by the infectious isoform, PrPsc, of a single cellular surface protein, PrPc. PrPsc is an insoluble form of PrPc and is believed to possess a different three-dimensional fold. It may propagate by causing PrPc to adopt its own infectious conformation by an unknown mechanism. Studies on folding and thermodynamic stability of prion proteins are essential for understanding the processes underlying the conversion from PrPc to PrPsc, but have so far been hampered by the low solubility of prion proteins in the absence of detergents. Here, we show that the amino-terminally truncated segment of mouse PrP comprising residues 121 to 231 is an autonomous folding unit. It consists predominantly of alpha-helical secondary structure and is soluble at high concentrations up to 1 mM in distilled water. PrP(121-231) undergoes a cooperative and completely reversible unfolding/refolding transition in the presence of guanidinium chloride with a free energy of folding of -22 kJ/mol at pH 7. The intrinsic stability of segment 121-231 is not in accordance with present models of the structure of PrPc and PrPsc PrP(121-231) may represent the only part of PrPc with defined three-dimensional structure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800210     DOI: 10.1006/jmbi.1996.0487

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations.

Authors:  S Supattapone; H O Nguyen; T Muramoto; F E Cohen; S J DeArmond; S B Prusiner; M Scott
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

Authors:  S Capellari; P Parchi; C M Russo; J Sanford; M S Sy; P Gambetti; R B Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Prion protein NMR structure and species barrier for prion diseases.

Authors:  M Billeter; R Riek; G Wider; S Hornemann; R Glockshuber; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.

Authors:  S Hornemann; R Glockshuber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Thermodynamic characterization of the unfolding of the prion protein.

Authors:  Roumita Moulick; Jayant B Udgaonkar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

7.  Protocol for aerosol-free recombinant production and NMR analysis of prion proteins.

Authors:  Peter Rehbein; Krishna Saxena; Kai Schlepckow; Harald Schwalbe
Journal:  J Biomol NMR       Date:  2014-04-26       Impact factor: 2.835

8.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform.

Authors:  T L James; H Liu; N B Ulyanov; S Farr-Jones; H Zhang; D G Donne; K Kaneko; D Groth; I Mehlhorn; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

9.  Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases.

Authors:  Grazia M Cereghetti; Arthur Schweiger; Rudi Glockshuber; Sabine Van Doorslaer
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

10.  Prion protein NMR structure and familial human spongiform encephalopathies.

Authors:  R Riek; G Wider; M Billeter; S Hornemann; R Glockshuber; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.